Poniard Pharmaceuticals, Inc.
PARD · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $24 | $65 | $17 | $34 |
| - Cash | $1 | $16 | $44 | $29 |
| + Debt | $2 | $20 | $25 | $11 |
| Enterprise Value | $25 | $69 | -$2 | $15 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$25 | -$39 | -$48 | -$30 |
| % Margin | – | – | – | – |
| Net Income | -$30 | -$46 | -$49 | -$33 |
| % Margin | – | – | – | – |
| EPS Diluted | -26.4 | -52.4 | -56.4 | -43.2 |
| % Growth | 49.6% | 7.1% | -30.6% | – |
| Operating Cash Flow | -$24 | -$35 | -$33 | -$25 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$6 |
| Free Cash Flow | -$24 | -$36 | -$34 | -$30 |